CeNeRx Biopharma Adds Dr. Daniel Burch as Chief Medical Officer Former GlaxoSmithKline Neurosciences Head Brings Broad Research & Development Expertise to Help Advance the Company’s CNS Portfolio Read more...
30-May-07
CeNeRx Announces Agreement with PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds Strategic Partnership Gives CeNeRx Rights to Develop and Commercialize Extensive Cannabinoid Pipeline for Pain and Other Disorders
Read more...
13-MAR-07
CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third
Generation RIMA Antidepressant Tyrima™ Demonstrates Good Safety Profile and Excellent Pharmacokinetic Properties Read more...
30-JAN-07
CeNeRx BioPharma Initiates Human Trials of RIMA Antidepressant First Subjects Dosed in Phase l Trial of Triple Action Agent Tyrima™ Read more...
13-Dec-05
CeNeRx BioPharma Appoints Chief Medical Officer Leading Research Scientist to Head CeNeRx Development Read more...
29-Nov-05
CeNeRx Announces $18.5 Million Series A Financing Start-up earns Triangle’s largest Q4 funding and 4th largest financing of 2005 Read more...
1-Nov-05
CeNeRx Announces License Agreement with Krenitsky Pharmaceuticals Strategic Partnership to Develop and Deliver Medicines for the Future Read more...
